Core Laboratories Inc

Core Laboratories Inc(CLB)の株式分析

$9.910

+0.538 (+5.43%)終値時点

Loading chart…
高値
10.000
始値
9.420
出来高加重平均価格
9.77
出来高
1.02M
時価総額
922.56M
安値
9.410
売買代金
9.96M
EV/EBITDA(TTM)
10.73

Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. It assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects.

www.corelab.com

AI分析 of Core Laboratories Inc (CLB)

中立

Core Laboratories Inc is currently a hold. The stock is priced at $9.91, with a forward P/E of 19.76, indicating potential overvaluation compared to its earnings growth. The RSI is at 48.22, suggesting the stock is neither overbought nor oversold, which may indicate a stable price point. However, the stock has seen a significant year-to-date decline of 41.53%, which raises concerns about its recovery potential in the near term. The main risk is the recent downgrade by BofA, which could lead to further price pressure.

アナリスト評価(18)

上値余地 +16.04%
買い
10 買い
8 中立
0 売り
現在: 9.91
安値
11.50
平均
11.50
高値
11.50

Johnson Rice

2026-08-13

目標株価

$21

買い

BofA

2026-07-15

目標株価

$11

アンダーパフォーム

Stifel

2025-07-16

目標株価

$12

中立

Citi

2025-05-13

目標株価

$13

中立

Stifel

2025-04-25

目標株価

$13

中立

バリュエーション指標

Core Laboratories Inc(CLB)の現在の予想PERは19.76で、5年平均は23.24です。

予想PER

適正
5年平均 P/E
23.24
現在のP/E
19.76
割高
31.48
割安
15.01

予想EV/EBITDA

適正
5年平均 EV/EBITDA
14.93
現在のEV/EBITDA
10.73
割高
19.88
割安
9.98

予想PSR

割安
5年平均 P/S
1.66
現在のP/S
0.82
割高
2.15
割安
1.17

Alphio AI による CLB の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%CLB

$12.15

シナリオ価格

基

基本

基本 · 50%CLB

$11.83

シナリオ価格

弱

弱気

弱気 · 25%CLB

$9.77

シナリオ価格

CLB を保有するクジラ

C

CWA Asset Management Group, LLC

+ を保有CLB

+5.99%

3か月リターン

A

Ariel Investments, LLC

+ を保有CLB

-4.55%

3か月リターン

イベントタイムライン

2026-07-29 (ET)

17:30:00

Sees Q3 Revenue of $128.5M-$135.5M

17:30:00

Core Lab Reports Q2 Revenue of $124.6M

2026-06-26 (ET)

17:30:00

S&P Global to Spin Off Mobility Global on July 1

2026-04-29 (ET)

17:00:00

Core Lab Q1 Revenue at $121.8M, Below Consensus

17:00:00

Sees Q2 Revenue of $123M-$131M

ニュース

CLB のよくある質問 — Alphio AI が回答

Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. It assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects. It operates in the Industrials sector (OIL & GAS FIELD SERVICES, NEC industry).

Core Laboratories Inc is currently a hold. The stock is priced at $9.91, with a forward P/E of 19.76, indicating potential overvaluation compared to its earnings growth. The RSI is at 48.22, suggesting the stock is neither overbought nor oversold, which may indicate a stable price point. However, the stock has seen a significant year-to-date decline of 41.53%, which raises concerns about its recovery potential in the near term. The main risk is the recent downgrade by BofA, which could lead to further price pressure.

18 analysts cover CLB: 10 rate it Buy, 8 Hold and 0 Sell. The average price target is 11.50.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める